Canada Markets closed

Abeona Therapeutics Inc. (ABEO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.1900-0.0200 (-1.65%)
At close: 4:00PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 5118.87M
Enterprise Value 355.15M
Trailing P/E N/A
Forward P/E 1-1.98
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)11.89
Price/Book (mrq)1.25
Enterprise Value/Revenue 35.51
Enterprise Value/EBITDA 7-1.21

Trading Information

Stock Price History

Beta (5Y Monthly) 1.39
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 33.7900
52 Week Low 30.9900
50-Day Moving Average 31.2532
200-Day Moving Average 31.5412

Share Statistics

Avg Vol (3 month) 31M
Avg Vol (10 day) 3427.01k
Shares Outstanding 599.89M
Implied Shares Outstanding 6N/A
Float 890.97M
% Held by Insiders 114.97%
% Held by Institutions 131.35%
Shares Short (Jul. 14, 2021) 44.77M
Short Ratio (Jul. 14, 2021) 43.4
Short % of Float (Jul. 14, 2021) 45.47%
Short % of Shares Outstanding (Jul. 14, 2021) 44.71%
Shares Short (prior month Jun. 14, 2021) 46.22M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:50
Last Split Date 3Oct. 23, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Jun. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)-490.40%

Management Effectiveness

Return on Assets (ttm)-20.78%
Return on Equity (ttm)-52.91%

Income Statement

Revenue (ttm)10M
Revenue Per Share (ttm)0.11
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-20.14M
EBITDA -45.71M
Net Income Avi to Common (ttm)-54.27M
Diluted EPS (ttm)-0.5590
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)77.56M
Total Cash Per Share (mrq)0.77
Total Debt (mrq)8.2M
Total Debt/Equity (mrq)9.75
Current Ratio (mrq)1.88
Book Value Per Share (mrq)0.95

Cash Flow Statement

Operating Cash Flow (ttm)-37.39M
Levered Free Cash Flow (ttm)-15.42M